Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Abstract 645: Network-based assessment of HDAC6 activity is highly predictive of pre-clinical and clinical responses to the HDAC6 inhibitor ricolinostat

Cancer Res (2021) 81 (13_Supplement): 645.

https://doi.org/10.1158/1538-7445.AM2021-645

Published: 01 July 2021

View article titled, Abstract 645: Network-based assessment of HDAC6 activity is highly predictive of pre-clinical and clinical responses to the HDAC6 inhibitor ricolinostat

Journal Articles

Abstract P1-19-27: Phase IB trial of ACY-1215 (ricolinostat) combined with nab-paclitaxel in metastatic breast cancer (MBC)

Kevin Kalinsky, Cody Chiuzan, Maika Onishi, Meghna S Trivedi, Melissa Accordino, Tizita Zeleke, Qingfei Pan, Sean Kelly, Erin Honan, Ruby Wu, Kathleen Fenn, Katherin D Crew, Dawn L Hershman, Matthew Maurer, Jiyang Yu, Jose Silva

Cancer Res (2020) 80 (4_Supplement): P1-19-27.

https://doi.org/10.1158/1538-7445.SABCS19-P1-19-27

Published: 15 February 2020

View article titled, Abstract P1-19-27: Phase IB trial of ACY-1215 (ricolinostat) combined with nab-paclitaxel in metastatic breast cancer (MBC)

Journal Articles

Abstract 693: A yeast synthetic lethal screen identifies a conserved interaction between PLK1 and CKS1b affecting cancer cell viability

Robert J. Reid, Xing Du, Ivana Sunjevaric, Vinayak Rayannavar, John Dittmar, Matthew Maurer, Rodney Rothstein

Cancer Res (2015) 75 (15_Supplement): 693.

https://doi.org/10.1158/1538-7445.AM2015-693

Published: 01 August 2015

View article titled, Abstract 693: A yeast synthetic lethal screen identifies a conserved interaction between PLK1 and CKS1b affecting cancer cell viability

Journal Articles

Abstract OT1-1-08: Master regulator (MR)-directed therapy in residual breast cancer patient derived xenografts (PDXs)

Kevin Kalinsky, Prabhjot Mundi, Dawn L Hershman, Eileen Connolly, Katherine D Crew, Hanina Hibshoosh, Andrea Calfiano, Matthew Maurer

Cancer Res (2015) 75 (9_Supplement): OT1-1-08.

https://doi.org/10.1158/1538-7445.SABCS14-OT1-1-08

Published: 01 May 2015

View article titled, Abstract OT1-1-08: Master regulator (MR)-directed therapy in residual breast cancer patient derived xenografts (PDXs)

Journal Articles

Abstract OT1-1-09: Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer

Kevin Kalinsky, Dow-Chung Chi, Shing Lee, Amy Tiersten, Della Makower, Ellen Chuang, Katherine D Crew, Dawn L Hershman, Jose Silva, Andrea Califano, Matthew Maurer

Cancer Res (2015) 75 (9_Supplement): OT1-1-09.

https://doi.org/10.1158/1538-7445.SABCS14-OT1-1-09

Published: 01 May 2015

View article titled, Abstract OT1-1-09: Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer

Journal Articles

Abstract P6-12-07: Discordance in cyclin D1 changes after metformin exposure by different protein expression methods: Results from a "Window of Opportunity" trial

Kevin Kalinsky, Hanina Hibshoosh, Tian Zheng, Katherine D Crew, Susan Refice, Sheldon Feldman, Bret Taback, Eileen Connolly, Matthew Maurer, Dawn L Hershman

Cancer Res (2015) 75 (9_Supplement): P6-12-07.

https://doi.org/10.1158/1538-7445.SABCS14-P6-12-07

Published: 01 May 2015

View article titled, Abstract P6-12-07: Discordance in cyclin D1 changes after metformin exposure by different protein expression methods: Results from a "Window of Opportunity" trial

Journal Articles

Abstract P5-01-05: Early optical tomography changes correlate with residual cancer burden scores in women receiving neoadjuvant chemotherapy

Emerson A Lim, Jacqueline E Gunther, Molly Flexman, Hyun K Kim, Hanina Hibshoosh, Kevin Kalinsky, Katherine Crew, Matthew Maurer, Sheldon Feldman, Bret Taback, Preya Ananthakrishnan, Margaret Chen, Susan Refice, Andreas Hielscher, Dawn L Hershman

Cancer Res (2015) 75 (9_Supplement): P5-01-05.

https://doi.org/10.1158/1538-7445.SABCS14-P5-01-05

Published: 01 May 2015

View article titled, Abstract P5-01-05: Early optical tomography changes correlate with residual cancer burden scores in women receiving neoadjuvant chemotherapy

Journal Articles

Abstract 5088: A synthetic genetic interaction screen in yeast identifies Plk1 as a promising therapeutic target in cancer cells that overexpress Cks1b

Robert J. D. Reid, Xing Du, John C. DIttmar, Vinayak Rayannavar, Ivana Sunjevaric, Matthew Maurer, Rodney Rothstein

Cancer Res (2014) 74 (19_Supplement): 5088.

https://doi.org/10.1158/1538-7445.AM2014-5088

Published: 01 October 2014

View article titled, Abstract 5088: A synthetic genetic interaction screen in yeast identifies Plk1 as a promising therapeutic target in cancer cells that overexpress Cks1b

Journal Articles

Abstract 2761: Characterizing the mechanism and the clinical relevance of the synthetic lethal interaction between STAT3 inhibition and HER2 overexpression in breast cancers

Ruth Rodriguez Barrueco, Jiyang Yu, Mariano Alvarez, Veronica Castro, Netonia Marshall, Ruoxi Su, Laura Castro, Matthew Maurer, Andrea Califano, Jose M Silva

Cancer Res (2014) 74 (19_Supplement): 2761.

https://doi.org/10.1158/1538-7445.AM2014-2761

Published: 01 October 2014

View article titled, Abstract 2761: Characterizing the mechanism and the clinical relevance of the synthetic lethal interaction between STAT3 inhibition and HER2 overexpression in breast cancers

Journal Articles

Abstract 2878: BCAM (breast cancer attractor metagenes): A new tool for assessing breast cancer prognosis

Wei-Yi Cheng, Tai-Hsien Ou Yang, Matthew Maurer, Dimitris Anastassiou

Cancer Res (2014) 74 (19_Supplement): 2878.

https://doi.org/10.1158/1538-7445.AM2014-2878

Published: 01 October 2014

View article titled, Abstract 2878: BCAM (breast cancer attractor metagenes): A new tool for assessing breast cancer prognosis

Journal Articles

Abstract 869: PTEN/PI3K oncogenic pathway profiling informs an in vivo synergistic therapeutic model for basal-like breast cancer.

Lao H. Saal, Qing-Bai She, Sofia K. Gruvberger-Saal, Matthew Maurer, Mervi Jumppanen, Tao Su, Meaghan Dendy, Ying-Ka I. Lau, Lorenzo Memeo, Markus Ringner, Jorma Isola, Hanina Hibshoosh, Neal Rosen, Ramon Parsons

Cancer Res (2013) 73 (8_Supplement): 869.

https://doi.org/10.1158/1538-7445.AM2013-869

Published: 15 April 2013

View article titled, Abstract 869: PTEN/PI3K oncogenic pathway profiling informs an in vivo synergistic therapeutic model for basal-like breast cancer.

Journal Articles

3-Phosphoinositide–Dependent Kinase 1 Potentiates Upstream Lesions on the Phosphatidylinositol 3-Kinase Pathway in Breast Carcinoma

Cancer Res (2009) 69 (15): 6299–6306.

https://doi.org/10.1158/0008-5472.CAN-09-0820

Published: 29 July 2009

View article titled, 3-Phosphoinositide–Dependent Kinase 1 Potentiates Upstream Lesions on the Phosphatidylinositol 3-Kinase Pathway in Breast Carcinoma

Includes: Supplementary data

Journal Articles

Abstract #4844: Candidate gene survey of common variants and ovarian cancer survival

Ellen Goode, Matthew Maurer, Thomas Sellers, Kimberly Kalli, Catherine Phelan, Brooke Fridley, Sebastian Armasu, Robert Vierkant, William Cliby, Linda Kelemen, Janet Olson, David Rider, Joellen Schildkraut, Julie Cunningham, Lynn Hartmann

Cancer Res (2009) 69 (9_Supplement): 4844.

Published: 01 May 2009

View article titled, Abstract #4844: Candidate gene survey of common variants and ovarian cancer survival

Journal Articles

An approach for assessing multi-SNP association with survival in a candidate gene setting

Matthew Maurer, Susan Geyer, Sophia Wang, Thomas Habermann, Stephen Ansell, Patricia Hartge, James Cerhan

Cancer Res (2007) 67 (9_Supplement): 47.

Published: 01 May 2007

View article titled, An approach for assessing multi-SNP association with survival in a candidate gene setting

Journal Articles

HIN-1, an Inhibitor of Cell Growth, Invasion, and AKT Activation

Ian Krop, Michele Taylor Parker, Noga Bloushtain-Qimron, Dale Porter, Rebecca Gelman, Hidefumi Sasaki, Matthew Maurer, Mary Beth Terry, Ramon Parsons, Kornelia Polyak

Cancer Res (2005) 65 (21): 9659–9669.

https://doi.org/10.1158/0008-5472.CAN-05-1663

Published: 01 November 2005

View article titled, HIN-1, an Inhibitor of Cell Growth, Invasion, and AKT Activation

Journal Articles

Methods for evaluating T cell receptor (TcR) repertoire via CDR3 spectratyping analysis

Susan Geyer, Matthew Maurer, Neil Kay, Ann Reed, Michael Strausbauch, Peter Wettstein

Cancer Res (2005) 65 (9_Supplement): 973.

Published: 01 May 2005

View article titled, Methods for evaluating T cell receptor (TcR) repertoire via CDR3 spectratyping analysis

Journal Articles

PIK3CA Mutations Correlate with Hormone Receptors, Node Metastasis, and ERBB2, and Are Mutually Exclusive with PTEN Loss in Human Breast Carcinoma

Lao H. Saal, Karolina Holm, Matthew Maurer, Lorenzo Memeo, Tao Su, Xiaomei Wang, Jennifer S. Yu, Per-Olof Malmström, Mahesh Mansukhani, Jens Enoksson, Hanina Hibshoosh, Åke Borg, Ramon Parsons

Cancer Res (2005) 65 (7): 2554–2559.

https://doi.org/10.1158/0008-5472-CAN-04-3913

Published: 01 April 2005

View article titled, <em>PIK3CA</em> Mutations Correlate with Hormone Receptors, Node Metastasis, and ERBB2, and Are Mutually Exclusive with PTEN Loss in Human Breast Carcinoma

Includes: Supplementary data

NARROW

Abstract 645: Network-based assessment of HDAC6 activity is highly predictive of pre-clinical and clinical responses to the HDAC6 inhibitor ricolinostat

Abstract P1-19-27: Phase IB trial of ACY-1215 (ricolinostat) combined with nab-paclitaxel in metastatic breast cancer (MBC)

Abstract 693: A yeast synthetic lethal screen identifies a conserved interaction between PLK1 and CKS1b affecting cancer cell viability

Abstract OT1-1-08: Master regulator (MR)-directed therapy in residual breast cancer patient derived xenografts (PDXs)

Abstract OT1-1-09: Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer

Abstract P6-12-07: Discordance in cyclin D1 changes after metformin exposure by different protein expression methods: Results from a "Window of Opportunity" trial

Abstract P5-01-05: Early optical tomography changes correlate with residual cancer burden scores in women receiving neoadjuvant chemotherapy

Abstract 5088: A synthetic genetic interaction screen in yeast identifies Plk1 as a promising therapeutic target in cancer cells that overexpress Cks1b

Abstract 2761: Characterizing the mechanism and the clinical relevance of the synthetic lethal interaction between STAT3 inhibition and HER2 overexpression in breast cancers

Abstract 2878: BCAM (breast cancer attractor metagenes): A new tool for assessing breast cancer prognosis

Abstract 869: PTEN/PI3K oncogenic pathway profiling informs an in vivo synergistic therapeutic model for basal-like breast cancer.

3-Phosphoinositide–Dependent Kinase 1 Potentiates Upstream Lesions on the Phosphatidylinositol 3-Kinase Pathway in Breast Carcinoma

Abstract #4844: Candidate gene survey of common variants and ovarian cancer survival

An approach for assessing multi-SNP association with survival in a candidate gene setting

HIN-1, an Inhibitor of Cell Growth, Invasion, and AKT Activation

Methods for evaluating T cell receptor (TcR) repertoire via CDR3 spectratyping analysis

PIK3CA Mutations Correlate with Hormone Receptors, Node Metastasis, and ERBB2, and Are Mutually Exclusive with PTEN Loss in Human Breast Carcinoma

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only